TAM
DERM icon

Tucker Asset Management’s Journey Medical DERM Stock Holding History

Tucker Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,600
Closed -$15K – 1680
2023
Q4 		$15K Buy
+2,600
New +$11.6K ﹤0.01% 609

Other funds holding DERM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Tucker Asset Management's DERM Position: Q1 2024 in Review

Tucker Asset Management sold out of Journey Medical (DERM) in Q1 2024, closing a stake of 2,600 shares — an estimated $15K sold.

Tucker Asset Management first reported a position in DERM in Q4 2023 and held it in 1 quarter. The position peaked at $15K in Q4 2023. 33 funds tracked by Wall St. Rank hold DERM as of Q1 2024.

  • Tucker Asset Management reported no remaining Journey Medical position as of Q1 2024 after selling out during the quarter.
  • Tucker Asset Management sold 2,600 Journey Medical shares in Q1 2024, an estimated $15K.
  • Tucker Asset Management first reported a position in Journey Medical in Q4 2023 and held it in 1 quarter.
  • Tucker Asset Management's Journey Medical position peaked at $15K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Journey Medical as of Q1 2024.

Based on Tucker Asset Management's 13F filing for Q1 2024, filed 9 Aug 2024.